JORDAN GREINER: Open Payments
NPI 1962885707 · PELLA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,856 in 66 payments from 16 companies in 2025. Trend: 2023 $942 · 2024 $1,773 · 2025 $1,856
Food & beverage: $1,518Education: $339
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $619 |
| UCB, Inc. | 10 | $323 |
| Novartis Pharmaceuticals Corporation | 7 | $213 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $190 |
| Regeneron Healthcare Solutions, Inc. | 3 | $136 |
| ABBVIE INC. | 3 | $71 |
| Lilly USA, LLC | 2 | $64 |
| PFIZER INC. | 3 | $53 |
| Amgen Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
Products named: TREMFYA, Bimzelx, ILUMYA, DUPIXENT, OTEZLA, SKYRIZI, COSENTYX, EUCRISA.
Industry payments across IA — which companies pay providers there.
